Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Public ClinicalTrials.gov record NCT00882258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Selective Progesterone Receptor Modulator Proellex (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Two (2) dose levels of Proellex or placebo will be administered once-daily for up to 91 days. Following screening and a pre-treatment endometrial biopsy, subjects will be followed monthly for the three month treatment phase.
Study identification
- NCT ID
- NCT00882258
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Mar 2007 (Actual)
- Completion
- Mar 2007 (Actual)
- Last update posted
- Jul 8, 2014
2006 – 2007
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, LLC | Birmingham | Alabama | 35235 | — |
| Women's Health Research | Phoenix | Arizona | 85015 | — |
| Arizona Wellness Centre for Women | Phoenix | Arizona | 85032 | — |
| Visions Clinical Research Tuscon | Tuscon | Arizona | 85712 | — |
| Medical Centre for Clinical Research | San Diego | California | 92108 | — |
| Women's Health Care, Inc. | San Diego | California | 92123 | — |
| Downtown Women's Health Care | Denver | Colorado | 80218 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33437 | — |
| Miami Research Associates, Women's Health Studies | Miami | Florida | 33143 | — |
| Insignia Clinical Research (Tampa Bay Women's Center) | Tampa | Florida | 33607 | — |
| Caring for Women | Las Vegas | Nevada | 89106 | — |
| Affiliated Clinical Research, Inc. | Las Vegas | Nevada | 89128 | — |
| SC Clinical Research Center | Columbia | South Carolina | 29201 | — |
| Advances in Health Inc. | Houston | Texas | 77030 | — |
| Obstetrical & Gynecolgical Associates, PA (OGA) | Houston | Texas | 77054 | — |
| Women's Clinical Research Centre | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00882258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00882258 live on ClinicalTrials.gov.